903129-71-5 Usage
Uses
Used in Pharmaceutical Development:
TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE is used as a key intermediate in the synthesis of pharmaceutical drugs for its potential anti-cancer, anti-inflammatory, and anti-viral properties.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE is used as a research compound to explore its therapeutic potential and optimize its properties for drug development.
Used in Drug Stability and Bioavailability Enhancement:
The tert-butyl group in TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE is used to improve the stability and bioavailability of the compound, making it a more effective candidate for drug development.
Used in Cancer Treatment:
TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE is used as a potential anti-cancer agent in oncology research, targeting various types of cancer through its therapeutic properties.
Used in Inflammation Management:
In the field of inflammation management, TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE is used as a potential anti-inflammatory agent to study its effects on reducing inflammation and related conditions.
Used in Antiviral Therapy:
TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE is used as a potential anti-viral agent in virology research, exploring its ability to inhibit viral replication and treat viral infections.
Check Digit Verification of cas no
The CAS Registry Mumber 903129-71-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,3,1,2 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 903129-71:
(8*9)+(7*0)+(6*3)+(5*1)+(4*2)+(3*9)+(2*7)+(1*1)=145
145 % 10 = 5
So 903129-71-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H13Cl2N3O2/c1-11(2,3)18-10(17)16-4-6-7(5-16)14-9(13)15-8(6)12/h4-5H2,1-3H3
903129-71-5Relevant articles and documents
INHIBITORS OF KRAS G12C
-
Paragraph 0118, (2021/04/02)
Disclosed herein are compounds that inhibit KRas G12C, pharmaceutical compositions, methods of preparation and uses thereof.
Pyrrolidine [3,4-d] pyrimidine derivatives, preparation method and its application
-
Paragraph 0114-0116, (2016/12/01)
The invention discloses a pyrrolidine[3,4-d]pyrimidine derivative and a preparation method and an application thereof. The pyrrolidine[3,4-d]pyrimidine derivative is an inhibitor of a type I insulin-like growth factor receptor (IGF-1R), and has a good IGF-1R inhibiting function and a good cancer cell proliferation inhibiting function, so that the pyrrolidine[3,4-d]pyrimidine derivative can be taken as a therapeutic agent for treating tumors and relevant diseases.